Finland· FI-REL-REL6039

Lunerin

A phenylpropanolamin, kombinationen product, registered in Finland by Aktiebolaget Draco.

ATC R01BA51

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLunerinATCR01BA51REGISTER NO.FI-REL-REL6039PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Aktiebolaget Draco
Country
Finland (FI)
ATC code
R01BA51
ATC class
Phenylpropanolamin, Kombinationen
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/47fc3539-1af5-4166-ac0a-9e3a146cdcad
GET /v1/drugs/47fc3539-1af5-4166-ac0a-9e3a146cdcad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "12",
  "form": "mikstuura",
  "route": null,
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "fenyylipropanoliamiini, yhdistelmävalmisteet",
  "ma_number": "7046",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL6039",
  "authorised_at": "1975-04-09"
}

See everything about phenylpropanolamin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.